Logo image of BAM.CA

BROOKFIELD ASSET MGMT-A (BAM.CA) Stock Fundamental Analysis

TSX:BAM - Toronto Stock Exchange - CA1130041058 - Common Stock - Currency: CAD

83.78  -2.75 (-3.18%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to BAM. BAM was compared to 81 industry peers in the Capital Markets industry. BAM has an average financial health and profitability rating. BAM is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year BAM was profitable.
In the past year BAM had a positive cash flow from operations.
Each year in the past 5 years BAM has been profitable.
Of the past 5 years BAM 4 years had a positive operating cash flow.
BAM.CA Yearly Net Income VS EBIT VS OCF VS FCFBAM.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

1.2 Ratios

With a decent Return On Assets value of 6.32%, BAM is doing good in the industry, outperforming 76.54% of the companies in the same industry.
BAM's Return On Equity of 9.08% is fine compared to the rest of the industry. BAM outperforms 72.84% of its industry peers.
BAM has a Return On Invested Capital of 4.07%. This is in the better half of the industry: BAM outperforms 71.60% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BAM is significantly below the industry average of 7.88%.
The last Return On Invested Capital (4.07%) for BAM is above the 3 year average (1.27%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.32%
ROE 9.08%
ROIC 4.07%
ROA(3y)9%
ROA(5y)7.21%
ROE(3y)13.06%
ROE(5y)12.5%
ROIC(3y)1.27%
ROIC(5y)3.38%
BAM.CA Yearly ROA, ROE, ROICBAM.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 66.67%, BAM belongs to the top of the industry, outperforming 83.95% of the companies in the same industry.
BAM's Profit Margin has improved in the last couple of years.
BAM's Operating Margin of 51.23% is amongst the best of the industry. BAM outperforms 80.25% of its industry peers.
BAM's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 51.23%
PM (TTM) 66.67%
GM N/A
OM growth 3Y-30.79%
OM growth 5Y-18.69%
PM growth 3Y22.85%
PM growth 5Y4.98%
GM growth 3YN/A
GM growth 5YN/A
BAM.CA Yearly Profit, Operating, Gross MarginsBAM.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 20 40 60 80 100

6

2. Health

2.1 Basic Checks

BAM has more shares outstanding than it did 1 year ago.
BAM has a better debt/assets ratio than last year.
BAM.CA Yearly Shares OutstandingBAM.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 100M 200M 300M 400M
BAM.CA Yearly Total Debt VS Total AssetsBAM.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

BAM has an Altman-Z score of 13.88. This indicates that BAM is financially healthy and has little risk of bankruptcy at the moment.
BAM's Altman-Z score of 13.88 is amongst the best of the industry. BAM outperforms 83.95% of its industry peers.
The Debt to FCF ratio of BAM is 2.09, which is a good value as it means it would take BAM, 2.09 years of fcf income to pay off all of its debts.
BAM has a better Debt to FCF ratio (2.09) than 76.54% of its industry peers.
A Debt/Equity ratio of 0.15 indicates that BAM is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.15, BAM is in the better half of the industry, outperforming 60.49% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 2.09
Altman-Z 13.88
ROIC/WACCN/A
WACCN/A
BAM.CA Yearly LT Debt VS Equity VS FCFBAM.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

A Current Ratio of 1.37 indicates that BAM should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.37, BAM is doing good in the industry, outperforming 60.49% of the companies in the same industry.
BAM has a Quick Ratio of 1.37. This is a normal value and indicates that BAM is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.37, BAM is doing good in the industry, outperforming 60.49% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 1.37
BAM.CA Yearly Current Assets VS Current LiabilitesBAM.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2B 4B 6B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 11.76% over the past year.
BAM shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -22.95% yearly.
Looking at the last year, BAM shows a very strong growth in Revenue. The Revenue has grown by 264.78%.
BAM shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -26.01% yearly.
EPS 1Y (TTM)11.76%
EPS 3Y-34.73%
EPS 5Y-22.95%
EPS Q2Q%21.21%
Revenue 1Y (TTM)264.78%
Revenue growth 3Y-46.15%
Revenue growth 5Y-26.01%
Sales Q2Q%-2.88%

3.2 Future

The Earnings Per Share is expected to grow by 15.74% on average over the next years. This is quite good.
The Revenue is expected to grow by 12.12% on average over the next years. This is quite good.
EPS Next Y13.8%
EPS Next 2Y15.04%
EPS Next 3Y15.74%
EPS Next 5YN/A
Revenue Next Year11.79%
Revenue Next 2Y12.78%
Revenue Next 3Y12.12%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BAM.CA Yearly Revenue VS EstimatesBAM.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
BAM.CA Yearly EPS VS EstimatesBAM.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

2

4. Valuation

4.1 Price/Earnings Ratio

BAM is valuated quite expensively with a Price/Earnings ratio of 40.09.
BAM's Price/Earnings ratio is a bit more expensive when compared to the industry. BAM is more expensive than 69.14% of the companies in the same industry.
BAM's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.54.
Based on the Price/Forward Earnings ratio of 31.73, the valuation of BAM can be described as expensive.
BAM's Price/Forward Earnings ratio is in line with the industry average.
BAM is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 35.28, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 40.09
Fwd PE 31.73
BAM.CA Price Earnings VS Forward Price EarningsBAM.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as BAM.
Industry RankSector Rank
P/FCF 134.01
EV/EBITDA N/A
BAM.CA Per share dataBAM.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of BAM may justify a higher PE ratio.
A more expensive valuation may be justified as BAM's earnings are expected to grow with 15.74% in the coming years.
PEG (NY)2.91
PEG (5Y)N/A
EPS Next 2Y15.04%
EPS Next 3Y15.74%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.05%, BAM has a reasonable but not impressive dividend return.
BAM's Dividend Yield is comparable with the industry average which is at 4.54.
BAM's Dividend Yield is comparable with the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 2.05%

5.2 History

BAM has been paying a dividend for over 5 years, so it has already some track record.
BAM has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years3
Div Non Decr Years3
BAM.CA Yearly Dividends per shareBAM.CA Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

125.58% of the earnings are spent on dividend by BAM. This is not a sustainable payout ratio.
DP125.58%
EPS Next 2Y15.04%
EPS Next 3Y15.74%
BAM.CA Yearly Income VS Free CF VS DividendBAM.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B
BAM.CA Dividend Payout.BAM.CA Dividend Payout, showing the Payout Ratio.BAM.CA Dividend Payout.PayoutRetained Earnings

BROOKFIELD ASSET MGMT-A

TSX:BAM (8/7/2025, 7:00:00 PM)

83.78

-2.75 (-3.18%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)05-06 2025-05-06/bmo
Earnings (Next)08-06 2025-08-06/bmo
Inst Owners17%
Inst Owner ChangeN/A
Ins Owners1.94%
Ins Owner ChangeN/A
Market Cap137.19B
Analysts68.57
Price Target81.23 (-3.04%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.05%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP125.58%
Div Incr Years3
Div Non Decr Years3
Ex-Date05-30 2025-05-30 (0.4375)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.17%
Min EPS beat(2)-1.13%
Max EPS beat(2)1.46%
EPS beat(4)2
Avg EPS beat(4)0.88%
Min EPS beat(4)-2.55%
Max EPS beat(4)5.74%
EPS beat(8)4
Avg EPS beat(8)1.73%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-17.41%
Min Revenue beat(2)-17.67%
Max Revenue beat(2)-17.15%
Revenue beat(4)0
Avg Revenue beat(4)-9.23%
Min Revenue beat(4)-17.67%
Max Revenue beat(4)-0.58%
Revenue beat(8)0
Avg Revenue beat(8)-8.6%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.87%
PT rev (3m)4.93%
EPS NQ rev (1m)-3.82%
EPS NQ rev (3m)-4.96%
EPS NY rev (1m)-0.69%
EPS NY rev (3m)-1.66%
Revenue NQ rev (1m)-0.77%
Revenue NQ rev (3m)-2.49%
Revenue NY rev (1m)0.38%
Revenue NY rev (3m)-0.71%
Valuation
Industry RankSector Rank
PE 40.09
Fwd PE 31.73
P/S 70.26
P/FCF 134.01
P/OCF 133.47
P/B 9.57
P/tB 9.57
EV/EBITDA N/A
EPS(TTM)2.09
EY2.49%
EPS(NY)2.64
Fwd EY3.15%
FCF(TTM)0.63
FCFY0.75%
OCF(TTM)0.63
OCFY0.75%
SpS1.19
BVpS8.76
TBVpS8.76
PEG (NY)2.91
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.32%
ROE 9.08%
ROCE 6.09%
ROIC 4.07%
ROICexc 4.18%
ROICexgc 4.38%
OM 51.23%
PM (TTM) 66.67%
GM N/A
FCFM 52.43%
ROA(3y)9%
ROA(5y)7.21%
ROE(3y)13.06%
ROE(5y)12.5%
ROIC(3y)1.27%
ROIC(5y)3.38%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)1.93%
ROCE(5y)4.85%
ROICexcg growth 3Y-36.28%
ROICexcg growth 5YN/A
ROICexc growth 3Y-36.35%
ROICexc growth 5YN/A
OM growth 3Y-30.79%
OM growth 5Y-18.69%
PM growth 3Y22.85%
PM growth 5Y4.98%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 2.09
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 31.61
Cash Conversion N/A
Profit Quality 78.65%
Current Ratio 1.37
Quick Ratio 1.37
Altman-Z 13.88
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)18.12%
Cap/Sales(5y)11.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.76%
EPS 3Y-34.73%
EPS 5Y-22.95%
EPS Q2Q%21.21%
EPS Next Y13.8%
EPS Next 2Y15.04%
EPS Next 3Y15.74%
EPS Next 5YN/A
Revenue 1Y (TTM)264.78%
Revenue growth 3Y-46.15%
Revenue growth 5Y-26.01%
Sales Q2Q%-2.88%
Revenue Next Year11.79%
Revenue Next 2Y12.78%
Revenue Next 3Y12.12%
Revenue Next 5YN/A
EBIT growth 1Y1072.58%
EBIT growth 3Y-62.73%
EBIT growth 5Y-39.83%
EBIT Next Year17.11%
EBIT Next 3Y17.48%
EBIT Next 5YN/A
FCF growth 1Y514.88%
FCF growth 3Y-25.34%
FCF growth 5Y-6.68%
OCF growth 1Y372.79%
OCF growth 3Y-24.26%
OCF growth 5Y-5.43%